$2.11
arrow_drop_up0.47%Key Stats | |
---|---|
Open | $2.14 |
Prev. Close | $2.10 |
EPS | -3.09 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $75.64M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.11 | 2.18 |
52 Week Range | 1.82 | 4.45 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -3.09 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024